TY  - GEN
AU  - Bekaii-Saab,Tanios
AU  - Phelps,Mitch A
AU  - Li,Xiaobai
AU  - Saji,Motoyasu
AU  - Goff,Laura
AU  - Kauh,John Sae Wook
AU  - O'Neil,Bert H
AU  - Balsom,Stephanie
AU  - Balint,Catherine
AU  - Liersemann,Ryan
AU  - Vasko,Vasily V
AU  - Bloomston,Mark
AU  - Marsh,William
AU  - Doyle,L Austin
AU  - Ellison,Gilian
AU  - Grever,Michael
AU  - Ringel,Matthew D
AU  - Villalona-Calero,Miguel A
TI  - Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers
SN  - 1527-7755
PY  - 2011///0812
KW  - Adult
KW  - Aged
KW  - Benzimidazoles
KW  - adverse effects
KW  - Biliary Tract Neoplasms
KW  - drug therapy
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - metabolism
KW  - Female
KW  - Humans
KW  - MAP Kinase Kinase 1
KW  - antagonists & inhibitors
KW  - MAP Kinase Kinase 2
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Phosphorylation
KW  - Proto-Oncogene Proteins
KW  - genetics
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins c-akt
KW  - Proto-Oncogene Proteins p21(ras)
KW  - ras Proteins
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1200/JCO.2010.33.9473
ER  -